Failed attempts at experimental transplantation and transmission of nocturnally-periodic simian Loa from monkey to man

Filaria Journal

Volumn 3, Issue , 2004, Pages

  Duke, B O L ^a  

^a River Blindness Foundation   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLCARBAMAZINE; IVERMECTIN; PENICILLIN G; PROGUANIL;

ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; BRAIN DISEASE; CENTRAL AFRICA; CHEMOPROPHYLAXIS; DRUG FATALITY; EXPERIMENTAL INFECTION; FILARIASIS; HISTOPATHOLOGY; HUMAN; INOCULATION; LARVAL STAGE; LOA LOA; NONHUMAN; ONCHOCERCIASIS; PARASITE TRANSMISSION; PERIODICITY; STRAIN DIFFERENCE; SUBCUTANEOUS TISSUE; VOLUNTEER;

EID: 13644252611     PISSN: 14752883     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2883-3-5     Document Type: Article

References (13)

1. Duke BOL, Wijers DJB: Studies on loiasis in monkeys. 1. The relationship between human and simian Loa in the rain-forest zone of the British Cameroons. Ann Trop Med Parasitol 1958, 52: 58-175.
2. Duke BOL: Studies on the biting habits of Chrysops. V. The biting cycles and infection rates of Chrysops silacea, C. dimidiata, C. langi and C. centurionis at canopy level in the rain-forest at Bombe, British Cameroons. Ann Trop Med Parasitol 1958, 52:24-35.
3. Duke BOL: Studies on loiasis in monkeys IV. Experimental hybridization of the human and simian strains of Loa. Ann Trop Med Parasitol 1964, 58:390-408.
4. Kivits M: Quatre cas d'encephalite mortelle avec invasion du cephalo-rachidien par microfilariae à Loa. Ann Soc Belge Med Trop 1952, 32:235-242.
5. Fain A, Elsen P, Wéry M, Maertens K: Les filarioses humaines au Mayumbe et dans les régions limitrophes (République du Zaire) Evaluation de la densité microfilarienne. Ann Soc Belg Med Trop 1974, 54:5-34.
6. Fain A: Les problèmes actuels de la loase. Bull World Health Organ 1978, 56:155-167.
7. Gardon J, Gardon-Wendel N, Demanga-Ngangué , Kamgno J, Chippaux JP, Boussinesq M: Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for onchocerciasis and loiasis. Lancet 1997, 350:18-22.
8. Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P, Chippaux JP: Three probable cases of Loa loa encephalopathy following treatment for onchocerciasis. Am J Trop Med Hyg 1998, 58: 61-469.
9. Boussinesq M, Gardon J, Kamgno J, Pion SDS, Gardon-Wendel N, Chippaux JP: Relationship between the prevalence and intensity of Loa loa infection in the Central Province of Cameroon. Ann Trop Med Parasitol 2001, 95:495-507.
10. Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux JP: Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J 2003, 2(Suppl 1):S4.
11. Twum-Danso NAY: Serious adverse events following treatment of onchocerciasis in Cameroon. Filaria J 2003, 2(Suppl 1 : 3.
12. Haselow NJ, Akamé J, Evini C, Akongo S: Programmatic and communication issues in relation to serious adverse events following treatment in areas co-endemic for onchocerciasis and loiasis. Filaria J 2003, 2(Suppl 1):S10.
13. Duke BOL: Studies on the chemoprophylaxis of loiasis. II. Observations on diethylcarbamazine citrate (Banocide) as a prophylactic in man. Ann Trop Med Parasitol 1963, 57:82-96.